{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:19:34Z","timestamp":1790421574402,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/leu.2017.139","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T02:41:13Z","timestamp":1494297673000},"page":"1661-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":110,"title":["The role of LNK\/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders"],"prefix":"10.1038","volume":"31","author":[{"given":"N","family":"Maslah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Cassinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Verger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J","family":"Kiladjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"BFleu2017139_CR1","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00005-012-0194-x","volume":"60","author":"L Velazquez","year":"2012","unstructured":"Velazquez L . The Lnk adaptor protein: a key regulator of normal and pathological hematopoiesis. Arch Immunol Ther Exp (Warsz) 2012; 60: 415\u2013429.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"BFleu2017139_CR2","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.1073\/pnas.92.25.11618","volume":"92","author":"X Huang","year":"1995","unstructured":"Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI . Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 1995; 92: 11618\u201311622.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017139_CR3","doi-asserted-by":"publisher","first-page":"14562","DOI":"10.1074\/jbc.272.23.14562","volume":"272","author":"S Takaki","year":"1997","unstructured":"Takaki S, Watts JD, Forbush KA, Nguyen NT, Hayashi J, Alberola-Ila J et al. Characterization of Lnk. An adaptor protein expressed in lymphocytes. J Biol Chem 1997; 272: 14562\u201314570.","journal-title":"J Biol Chem"},{"key":"BFleu2017139_CR4","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.4049\/jimmunol.164.10.5199","volume":"164","author":"Y Li","year":"2000","unstructured":"Li Y, He X, Schembri-King J, Jakes S, Hayashi J . Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 2000; 164: 5199\u20135206.","journal-title":"J Immunol"},{"key":"BFleu2017139_CR5","doi-asserted-by":"publisher","first-page":"20148","DOI":"10.1074\/jbc.M510997200","volume":"281","author":"J Fitau","year":"2006","unstructured":"Fitau J, Boulday G, Coulon F, Quillard T, Charreau B . The adaptor molecule Lnk negatively regulates tumor necrosis factor-alpha-dependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 2006; 281: 20148\u201320159.","journal-title":"J Biol Chem"},{"key":"BFleu2017139_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCRESAHA.108.192856","volume":"104","author":"S-M Kwon","year":"2009","unstructured":"Kwon S-M, Suzuki T, Kawamoto A, Ii M, Eguchi M, Akimaru H et al. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Circ Res 2009; 104: 969\u2013977.","journal-title":"Circ Res"},{"key":"BFleu2017139_CR7","doi-asserted-by":"publisher","first-page":"e26433","DOI":"10.1371\/journal.pone.0026433","volume":"6","author":"T-C Wang","year":"2011","unstructured":"Wang T-C, Chiu H, Chang Y-J, Hsu T-Y, Chiu I-M, Chen L . The adaptor protein SH2B3 (Lnk) negatively regulates neurite outgrowth of PC12 cells and cortical neurons. PLoS ONE 2011; 6: e26433.","journal-title":"PLoS ONE"},{"key":"BFleu2017139_CR8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1084\/jem.20011883","volume":"195","author":"L Velazquez","year":"2002","unstructured":"Velazquez L, Cheng AM, Fleming HE, Furlonger C, Vesely S, Bernstein A et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 2002; 195: 1599\u20131611.","journal-title":"J Exp Med"},{"key":"BFleu2017139_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nsmb829","volume":"11","author":"S Dhe-Paganon","year":"2004","unstructured":"Dhe-Paganon S, Werner ED, Nishi M, Hansen L, Chi Y-I, Shoelson SE . A phenylalanine zipper mediates APS dimerization. Nat Struct Mol Biol 2004; 11: 968\u2013974.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu2017139_CR10","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1128\/MCB.25.7.2607-2621.2005","volume":"25","author":"M Nishi","year":"2005","unstructured":"Nishi M, Werner ED, Oh B-C, Frantz JD, Dhe-Paganon S, Hansen L et al. Kinase activation through dimerization by human SH2-B. Mol Cell Biol 2005; 25: 2607\u20132621.","journal-title":"Mol Cell Biol"},{"key":"BFleu2017139_CR11","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1182\/blood-2005-05-2138","volume":"107","author":"H Takizawa","year":"2006","unstructured":"Takizawa H, Kubo-Akashi C, Nobuhisa I, Kwon S-M, Iseki M, Taga T et al. Enhanced engraftment of hematopoietic stem\/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood 2006; 107: 2968\u20132975.","journal-title":"Blood"},{"key":"BFleu2017139_CR12","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1182\/blood-2007-05-089326","volume":"110","author":"S Gery","year":"2007","unstructured":"Gery S, Gueller S, Chumakova K, Kawamata N, Liu L, Koeffler HP . Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders. Blood 2007; 110: 3360\u20133364.","journal-title":"Blood"},{"key":"BFleu2017139_CR13","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1182\/blood-2004-10-4093","volume":"105","author":"W Tong","year":"2005","unstructured":"Tong W, Zhang J, Lodish HF . Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 2005; 105: 4604\u20134612.","journal-title":"Blood"},{"key":"BFleu2017139_CR14","first-page":"2832","volume":"118","author":"A Bersenev","year":"2008","unstructured":"Bersenev A, Wu C, Balcerek J, Tong W . Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest 2008; 118: 2832\u20132844.","journal-title":"J Clin Invest"},{"key":"BFleu2017139_CR15","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1182\/blood-2008-05-154849","volume":"112","author":"C Simon","year":"2008","unstructured":"Simon C, Dondi E, Chaix A, de Sepulveda P, Kubiseski TJ, Varin-Blank N et al. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Blood 2008; 112: 4039\u20134047.","journal-title":"Blood"},{"key":"BFleu2017139_CR16","doi-asserted-by":"publisher","first-page":"5961","DOI":"10.1182\/blood-2009-12-256768","volume":"116","author":"F Baran-Marszak","year":"2010","unstructured":"Baran-Marszak F, Magdoud H, Desterke C, Alvarado A, Roger C, Harel S et al. Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms. Blood 2010; 116: 5961\u20135971.","journal-title":"Blood"},{"key":"BFleu2017139_CR17","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1073\/pnas.0606238104","volume":"104","author":"J Seita","year":"2007","unstructured":"Seita J, Ema H, Ooehara J, Yamazaki S, Tadokoro Y, Yamasaki A et al. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci USA 2007; 104: 2349\u20132354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2017139_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1084\/jem.20011170","volume":"195","author":"S Takaki","year":"2002","unstructured":"Takaki S, Morita H, Tezuka Y, Takatsu K . Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med 2002; 195: 151\u2013160.","journal-title":"J Exp Med"},{"key":"BFleu2017139_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/S1074-7613(00)00060-1","volume":"13","author":"S Takaki","year":"2000","unstructured":"Takaki S, Sauer K, Iritani BM, Chien S, Ebihara Y, Tsuji K et al. Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity 2000; 13: 599\u2013609.","journal-title":"Immunity"},{"key":"BFleu2017139_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.devcel.2005.03.019","volume":"8","author":"H Ema","year":"2005","unstructured":"Ema H, Sudo K, Seita J, Matsubara A, Morita Y, Osawa M et al. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell 2005; 8: 907\u2013914.","journal-title":"Dev Cell"},{"key":"BFleu2017139_CR21","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1101\/gad.385606","volume":"20","author":"N Buza-Vidas","year":"2006","unstructured":"Buza-Vidas N, Antonchuk J, Qian H, M\u00e5nsson R, Luc S, Zandi S et al. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev 2006; 20: 2018\u20132023.","journal-title":"Genes Dev"},{"key":"BFleu2017139_CR22","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/JCI81468","volume":"126","author":"Y Cheng","year":"2016","unstructured":"Cheng Y, Chikwava K, Wu C, Zhang H, Bhagat A, Pei D et al. LNK\/SH2B3 regulates IL-7 receptor signaling in normal and malignant B-progenitors. J Clin Invest 2016; 126: 1267\u20131281.","journal-title":"J Clin Invest"},{"key":"BFleu2017139_CR23","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20040762","volume":"200","author":"W Tong","year":"2004","unstructured":"Tong W, Lodish HF . Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 2004; 200: 569\u2013580.","journal-title":"J Exp Med"},{"key":"BFleu2017139_CR24","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.exphem.2008.02.004","volume":"36","author":"H Takizawa","year":"2008","unstructured":"Takizawa H, Eto K, Yoshikawa A, Nakauchi H, Takatsu K, Takaki S . Growth and maturation of megakaryocytes is regulated by Lnk\/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals. Exp Hematol 2008; 36: 897\u2013906.","journal-title":"Exp Hematol"},{"key":"BFleu2017139_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1172\/JCI39503","volume":"120","author":"H Takizawa","year":"2010","unstructured":"Takizawa H, Nishimura S, Takayama N, Oda A, Nishikii H, Morita Y et al. Lnk regulates integrin alphaIIbbeta3 outside-in signaling in mouse platelets, leading to stabilization of thrombus development in vivo. J Clin Invest 2010; 120: 179\u2013190.","journal-title":"J Clin Invest"},{"key":"BFleu2017139_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/sj.leu.2401397","volume":"13","author":"T Wakioka","year":"1999","unstructured":"Wakioka T, Sasaki A, Mitsui K, Yokouchi M, Inoue A, Komiya S et al. APS, an adaptor protein containing Pleckstrin homology (PH) and Src homology-2 (SH2) domains inhibits the JAK-STAT pathway in collaboration with c-Cbl. Leukemia 1999; 13: 760\u2013767.","journal-title":"Leukemia"},{"key":"BFleu2017139_CR27","doi-asserted-by":"publisher","first-page":"26223","DOI":"10.1074\/jbc.M112.382721","volume":"287","author":"M Javadi","year":"2012","unstructured":"Javadi M, Hofst\u00e4tter E, Stickle N, Beattie BK, Jaster R, Carter-Su C et al. The SH2B1 adaptor protein associates with a proximal region of the erythropoietin receptor. J Biol Chem 2012; 287: 26223\u201326234.","journal-title":"J Biol Chem"},{"key":"BFleu2017139_CR28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1189\/jlb.0908575","volume":"85","author":"S Gery","year":"2009","unstructured":"Gery S, Cao Q, Gueller S, Xing H, Tefferi A, Koeffler HP . Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leukoc Biol 2009; 85: 957\u2013965.","journal-title":"J Leukoc Biol"},{"key":"BFleu2017139_CR29","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/MCB.00570-06","volume":"26","author":"JH Kurzer","year":"2006","unstructured":"Kurzer JH, Saharinen P, Silvennoinen O, Carter-Su C . Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol 2006; 26: 6381\u20136394.","journal-title":"Mol Cell Biol"},{"key":"BFleu2017139_CR30","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/bjh.12327","volume":"161","author":"M Koren-Michowitz","year":"2013","unstructured":"Koren-Michowitz M, Gery S, Tabayashi T, Lin D, Alvarez R, Nagler A et al. SH2B3 (LNK) mutations from myeloproliferative neoplasms patients have mild loss of function against wild type JAK2 and JAK2 V617F. Br J Haematol 2013; 161: 811\u2013820.","journal-title":"Br J Haematol"},{"key":"BFleu2017139_CR31","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1172\/JCI59719","volume":"122","author":"J Jiang","year":"2012","unstructured":"Jiang J, Balcerek J, Rozenova K, Cheng Y, Bersenev A, Wu C et al. 14-3-3 regulates the LNK\/JAK2 pathway in mouse hematopoietic stem and progenitor cells. J Clin Invest 2012; 122: 2079\u20132091.","journal-title":"J Clin Invest"},{"key":"BFleu2017139_CR32","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1172\/JCI42032","volume":"120","author":"A Bersenev","year":"2010","unstructured":"Bersenev A, Wu C, Balcerek J, Jing J, Kundu M, Blobel GA et al. Lnk constrains myeloproliferative diseases in mice. J Clin Invest 2010; 120: 2058\u20132069.","journal-title":"J Clin Invest"},{"key":"BFleu2017139_CR33","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1182\/blood-2014-05-579136","volume":"124","author":"A Tefferi","year":"2014","unstructured":"Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis. Blood 2014; 124: 2507\u20132513, quiz 2615.","journal-title":"Blood"},{"key":"BFleu2017139_CR34","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","volume":"369","author":"T Klampfl","year":"2013","unstructured":"Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369: 2379\u20132390.","journal-title":"N Engl J Med"},{"key":"BFleu2017139_CR35","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1182\/blood-2006-04-018879","volume":"108","author":"AD Pardanani","year":"2006","unstructured":"Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006; 108: 3472\u20133476.","journal-title":"Blood"},{"key":"BFleu2017139_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/ajh.24259","volume":"91","author":"MF McMullin","year":"2016","unstructured":"McMullin MF, Cario H . LNK mutations and myeloproliferative disorders. Am J Hematol 2016; 91: 248\u2013251.","journal-title":"Am J Hematol"},{"key":"BFleu2017139_CR37","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1182\/blood-2010-02-270108","volume":"116","author":"ST Oh","year":"2010","unstructured":"Oh ST, Simonds EF, Jones C, Hale MB, Goltsev Y, Gibbs KD et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 2010; 116: 988\u2013992.","journal-title":"Blood"},{"key":"BFleu2017139_CR38","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1182\/blood-2010-02-270108","volume":"116","author":"ST Oh","year":"2010","unstructured":"Oh ST, Zahn JM, Jones CD, Zhang B, Loh ML, Kantarjian H et al. Identification of novel LNK mutations in patients with chronic myeloproliferative neoplasms and related disorders. Blood 2010; 116: 315\u2013315.","journal-title":"Blood"},{"key":"BFleu2017139_CR39","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ajh.22107","volume":"86","author":"J-S Ha","year":"2011","unstructured":"Ha J-S, Jeon D-S . Possible new LNK mutations in myeloproliferative neoplasms. Am J Hematol 2011; 86: 866\u2013868.","journal-title":"Am J Hematol"},{"key":"BFleu2017139_CR40","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.leukres.2011.07.009","volume":"35","author":"C Hurtado","year":"2011","unstructured":"Hurtado C, Erquiaga I, Aranaz P, Migu\u00e9liz I, Garc\u00eda-Delgado M, Novo FJ et al. LNK can also be mutated outside PH and SH2 domains in myeloproliferative neoplasms with and without V617FJAK2 mutation. Leuk Res 2011; 35: 1537\u20131539.","journal-title":"Leuk Res"},{"key":"BFleu2017139_CR41","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/leu.2010.163","volume":"24","author":"A Pardanani","year":"2010","unstructured":"Pardanani A, Lasho T, Finke C, Oh ST, Gotlib J, Tefferi A . LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia 2010; 24: 1713\u20131718.","journal-title":"Leukemia"},{"key":"BFleu2017139_CR42","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/leu.2011.45","volume":"25","author":"TL Lasho","year":"2011","unstructured":"Lasho TL, Tefferi A, Finke C, Pardanani A . Clonal hierarchy and allelic mutation segregation in a myelofibrosis patient with two distinct LNK mutations. Leukemia 2011; 25: 1056\u20131058.","journal-title":"Leukemia"},{"key":"BFleu2017139_CR43","doi-asserted-by":"publisher","first-page":"e0154183","DOI":"10.1371\/journal.pone.0154183","volume":"11","author":"Y Chen","year":"2016","unstructured":"Chen Y, Fang F, Hu Y, Liu Q, Bu D, Tan M et al. The polymorphisms in LNK gene correlated to the clinical type of myeloproliferative neoplasms. PLoS ONE 2016; 11: e0154183.","journal-title":"PLoS ONE"},{"key":"BFleu2017139_CR44","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMc1006966","volume":"363","author":"TL Lasho","year":"2010","unstructured":"Lasho TL, Pardanani A, Tefferi A . LNK mutations in JAK2 mutation-negative erythrocytosis. N Engl J Med 2010; 363: 1189\u20131190.","journal-title":"N Engl J Med"},{"key":"BFleu2017139_CR45","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.3324\/haematol.2013.090175","volume":"98","author":"A Spolverini","year":"2013","unstructured":"Spolverini A, Pieri L, Guglielmelli P, Pancrazzi A, Fanelli T, Paoli C et al. Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative \u2018idiopathic\u2019 erythrocytosis. Haematologica 2013; 98: e101\u2013e102.","journal-title":"Haematologica"},{"key":"BFleu2017139_CR46","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/ajh.22154","volume":"86","author":"MF McMullin","year":"2011","unstructured":"McMullin MF, Wu C, Percy MJ, Tong W . A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis. Am J Hematol 2011; 86: 962\u2013964.","journal-title":"Am J Hematol"},{"key":"BFleu2017139_CR47","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.3324\/haematol.2016.144063","volume":"101","author":"C Camps","year":"2016","unstructured":"Camps C, Petousi N, Bento C, Cario H, Copley RR, McMullin MF et al. Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations. Haematologica 2016; 101: 1306\u20131318.","journal-title":"Haematologica"},{"key":"BFleu2017139_CR48","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","volume":"359","author":"DJ Smyth","year":"2008","unstructured":"Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JHM et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767\u20132777.","journal-title":"N Engl J Med"},{"key":"BFleu2017139_CR49","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4239\/wjd.v5.i3.316","volume":"5","author":"G Auburger","year":"2014","unstructured":"Auburger G, Gispert S, Lahut S, Om\u00fcr O, Damrath E, Heck M et al. 12q24 locus association with type 1 diabetes: SH2B3 or ATXN2? World J Diabetes 2014; 5: 316\u2013327.","journal-title":"World J Diabetes"},{"key":"BFleu2017139_CR50","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/ng.323","volume":"41","author":"DF Gudbjartsson","year":"2009","unstructured":"Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009; 41: 342\u2013347.","journal-title":"Nat Genet"},{"key":"BFleu2017139_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng.102","volume":"40","author":"KA Hunt","year":"2008","unstructured":"Hunt KA, Zhernakova A, Turner G, Heap GAR, Franke L, Bruinenberg M et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008; 40: 395\u2013402.","journal-title":"Nat Genet"},{"key":"BFleu2017139_CR52","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ajhg.2010.05.004","volume":"86","author":"A Zhernakova","year":"2010","unstructured":"Zhernakova A, Elbers CC, Ferwerda B, Romanos J, Trynka G, Dubois PC et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 2010; 86: 970\u2013977.","journal-title":"Am J Hum Genet"},{"key":"BFleu2017139_CR53","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gene.2010.30","volume":"11","author":"A Alcina","year":"2010","unstructured":"Alcina A, Vandenbroeck K, Otaegui D, Saiz A, Gonzalez JR, Fernandez O et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun 2010; 11: 439\u2013445.","journal-title":"Genes Immun"},{"key":"BFleu2017139_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1399-5448.2010.00656.x","volume":"12","author":"EY Lavrikova","year":"2011","unstructured":"Lavrikova EY, Nikitin AG, Kuraeva TL, Peterkova VA, Tsitlidze NM, Chistiakov DA et al. The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr Diabetes 2011; 12: 127\u2013132.","journal-title":"Pediatr Diabetes"},{"key":"BFleu2017139_CR55","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng.361","volume":"41","author":"C Newton-Cheh","year":"2009","unstructured":"Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009; 41: 666\u2013676.","journal-title":"Nat Genet"},{"key":"BFleu2017139_CR56","doi-asserted-by":"publisher","first-page":"e1001184","DOI":"10.1371\/journal.pgen.1001184","volume":"6","author":"MK Ikram","year":"2010","unstructured":"Ikram MK, Sim X, Xueling S, Jensen RA, Cotch MF, Hewitt AW et al. Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet 2010; 6: e1001184.","journal-title":"PLoS Genet"},{"key":"BFleu2017139_CR57","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCGENETICS.114.000527","volume":"8","author":"MJ Flister","year":"2015","unstructured":"Flister MJ, Hoffman MJ, Lemke A, Prisco SZ, Rudemiller N, O\u2019Meara CC et al. SH2B3 is a genetic determinant of cardiac inflammation and fibrosis. Circ Cardiovasc Genet 2015; 8: 294\u2013304.","journal-title":"Circ Cardiovasc Genet"},{"key":"BFleu2017139_CR58","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/MNH.0000000000000196","volume":"25","author":"BL Dale","year":"2016","unstructured":"Dale BL, Madhur MS . Linking inflammation and hypertension via LNK\/SH2B3. Curr Opin Nephrol Hypertens 2016; 25: 87\u201393.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"BFleu2017139_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3324\/haematol.2010.035287","volume":"96","author":"ME Daly","year":"2011","unstructured":"Daly ME . Determinants of platelet count in humans. Haematologica 2011; 96: 10\u201313.","journal-title":"Haematologica"},{"key":"BFleu2017139_CR60","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1038\/ng.467","volume":"41","author":"N Soranzo","year":"2009","unstructured":"Soranzo N, Spector TD, Mangino M, K\u00fchnel B, Rendon A, Teumer A et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009; 41: 1182\u20131190.","journal-title":"Nat Genet"},{"key":"BFleu2017139_CR61","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ng.466","volume":"41","author":"SK Ganesh","year":"2009","unstructured":"Ganesh SK, Zakai NA, van Rooij FJA, Soranzo N, Smith AV, Nalls MA et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet 2009; 41: 1191\u20131198.","journal-title":"Nat Genet"},{"key":"BFleu2017139_CR62","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1182\/blood-2013-10-532622","volume":"123","author":"E Lesteven","year":"2014","unstructured":"Lesteven E, Picque M, Conejero Tonetti C, Giraudier S, Varin-Blank N, Velazquez L et al. Association of a single-nucleotide polymorphism in the SH2B3 gene with JAK2V617F-positive myeloproliferative neoplasms. Blood 2014; 123: 794\u2013796.","journal-title":"Blood"},{"key":"BFleu2017139_CR63","first-page":"e91","volume":"19","author":"W Wang","year":"2016","unstructured":"Wang W, Tang Y, Wang Y, Tascau L, Balcerek J, Tong W et al. LNK\/SH2B3 loss of function promotes atherosclerosis and thrombosis. Circ Res 2016; 19: e91\u2013e103.","journal-title":"Circ Res"},{"key":"BFleu2017139_CR64","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood-2015-06-652941","volume":"128","author":"DA Hinds","year":"2016","unstructured":"Hinds DA, Barnholt KE, Mesa RA, Kiefer AK, Do CB, Eriksson N et al. Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. Blood 2016; 128: 1121\u20131128.","journal-title":"Blood"},{"key":"BFleu2017139_CR65","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1038\/ncomms8138","volume":"6","author":"FR Schumacher","year":"2015","unstructured":"Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nat Commun 2015; 6: 7138.","journal-title":"Nat Commun"},{"key":"BFleu2017139_CR66","doi-asserted-by":"publisher","first-page":"djv246","DOI":"10.1093\/jnci\/djv246","volume":"107","author":"RJ Hung","year":"2015","unstructured":"Hung RJ, Ulrich CM, Goode EL, Brhane Y, Muir K, Chan AT et al. Cross cancer genomic investigation of inflammation pathway for five common cancers: lung, ovary, prostate, breast, and colorectal cancer. J Natl Cancer Inst 2015; 107: djv246.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2017139_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2016-04-711150","volume":"128","author":"E Rumi","year":"2016","unstructured":"Rumi E, Harutyunyan AS, Pietra D, Feenstra JDM, Cavalloni C, Roncoroni E et al. LNK mutations in familial myeloproliferative neoplasms. Blood 2016; 128: 144\u2013145.","journal-title":"Blood"},{"key":"BFleu2017139_CR68","doi-asserted-by":"publisher","first-page":"E356","DOI":"10.1002\/ajh.24437","volume":"91","author":"GG Loscocco","year":"2016","unstructured":"Loscocco GG, Mannarelli C, Pacilli A, Fanelli T, Rotunno G, Gesullo F et al. Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms. Am J Hematol 2016; 91: E356.","journal-title":"Am J Hematol"},{"key":"BFleu2017139_CR69","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu2017139_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","volume":"22","author":"KG Roberts","year":"2012","unstructured":"Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 2012; 22: 153\u2013166.","journal-title":"Cancer Cell"},{"key":"BFleu2017139_CR71","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1182\/blood-2013-05-500850","volume":"122","author":"A Perez-Garcia","year":"2013","unstructured":"Perez-Garcia A, Ambesi-Impiombato A, Hadler M, Rigo I, LeDuc CA, Kelly K et al. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood 2013; 122: 2425\u20132432.","journal-title":"Blood"},{"key":"BFleu2017139_CR72","doi-asserted-by":"publisher","first-page":"64071","DOI":"10.18632\/oncotarget.11773","volume":"7","author":"CM Lindqvist","year":"2016","unstructured":"Lindqvist CM, Lundmark A, Nordlund J, Freyhult E, Ekman D, Carlsson Alml\u00f6f J et al. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes. Oncotarget 2016; 7: 64071\u201364088.","journal-title":"Oncotarget"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2017139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2017139","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/leu.2017.139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/leu2017139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:28:36Z","timestamp":1648733316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2017139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFleu2017139"],"URL":"https:\/\/doi.org\/10.1038\/leu.2017.139","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]},"assertion":[{"value":"2 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}